The cobas® c 703 and cobas® ISE neo analytical units, deliver higher testing capacity and increased automation helping to improve laboratory workflows and advance patient care. The new cobas c 703 ...
With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs This will allow a greater number of ...
The MarketWatch News Department was not involved in the creation of this content. -- The cobas(R) c 703 and cobas(R) ISE neo analytical units deliver higher testing capacity and increased automation, ...
Roche announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its newest analytical units – the cobas® c 703 and cobas® ISE neo. As part of the scalable and modular cobas® pro ...
(RTTNews) - Roche (RHHBY) announced the release eight new high throughput configurations for cobas pro integrated solutions which have been designed to address the individual needs of healthcare ...
* ROCHE DIAGNOSTICS ANNOUNCED TODAY THAT US FOOD AND DRUG ADMINISTRATION (FDA) HAS CLEARED ITS COBAS PROⓇ INTEGRATED SOLUTIONS, A NEW GENERATION OF SERUM WORK AREA (CLINICAL CHEMISTRY AND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results